Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Original publication

DOI

10.1002/art.39269

Type

Journal article

Journal

Arthritis Rheumatol

Publication Date

09/2015

Volume

67

Pages

2283 - 2291

Keywords

Angiogenesis Inhibitors, Antirheumatic Agents, Arthritis, Rheumatoid, Drug Discovery, Drug Therapy, Combination, Humans, Interleukin-17, Molecular Targeted Therapy, Receptors, Tumor Necrosis Factor, Type I, Rheumatology, Tumor Necrosis Factor-alpha